Evidence map›Paper›PMID 37947546›Full record

Observational studyInternational journal of environmental research and public health2023

Survey on the Mental Health of Dispensing Pharmacists in the Auvergne-Rhône-Alpes Region (France).

Bernard Massoubre, Tristan Gabriel-Segard, Florence Durupt, Anne-Sophie Malachane, Noémie Anglard, Théophile Tiffet, Catherine Massoubre

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bernard MassoubreInstitute of Pharmaceutical and Biological Sciences (ISPB), 6 Avenue Rockefeller, 69008 Lyon, France.
Tristan Gabriel-SegardUniversity Department of Psychiatry, University Hospital Centre of Saint-Etienne, 42055 Saint-Etienne, France.
Florence DuruptURPS-Pharmaciens Auvergne Rhône-Alpes, 194 bis Rue Garibaldi, 69003 Lyon, France.
Anne-Sophie MalachaneURPS-Pharmaciens Auvergne Rhône-Alpes, 194 bis Rue Garibaldi, 69003 Lyon, France.
Noémie AnglardURPS-Pharmaciens Auvergne Rhône-Alpes, 194 bis Rue Garibaldi, 69003 Lyon, France.
Théophile TiffetPublic Health Service, University Hospital Centre of Saint-Etienne, 42055 Saint-Etienne, France.ORCID 0000-0003-2975-0553
Catherine MassoubreUniversity Department of Psychiatry, University Hospital Centre of Saint-Etienne, EA TAPE 7423, University Jean Monnet, 42055 Saint-Etienne, France.
Centre Hospitalier Universitaire de Saint-Étienne · FRUniversité Jean Monnet · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic intensely involved pharmacists in France, with new responsibilities on a large scale, introducing to dispensary practice the performance of vaccination and nasopharyngeal swabs. This study aimed to assess the prevalence of burnout, anxiety, and depression in pharmacists after the COVID-19 health crisis and to identify factors associated with psychological distress.

methodsA cross-sectional observational study involved 1700 pharmacies in an entire French region. Sociodemographic, geographical, and medical information (burnout tested with the MBI and anxiety/depression measured on the HAD scale) were collected via an online anonymous self-administered questionnaire. The characteristics of the pharmacy and the practice of antigen testing and vaccination were requested. Quantitative and qualitative variables associated with psychological distress were investigated with a factor analysis.

resultsIn total, 360 responses were collected (20.5%). Of the responses, 41.9% showed definite anxiety symptoms and 18.3% showed proven depressive symptoms. Three clusters were described according to the intensity of burnout experience, depersonalization, and loss of personal accomplishment. The analysis identified that one cluster was at high risk of burnout (high burnout and depersonalization scores). Of these stressed, exhausted pharmacists, 69.3% showed definite anxiety, 37.9% showed proven depression, and in smaller pharmacies. The carrying out of antigenic testing and anti-COVID vaccination, as well as the geographical location of the pharmacy, were not discriminating factors in these three groups.

conclusionMental health care and suicide prevention should be provided to at-risk pharmacists. It seems essential to publicize the range of resources available to support pharmacists.

Indexed as

Burnout, ProfessionalCOVID-19Cross-Sectional StudiesHumansMental HealthPandemicsPharmacistsSurveys and Questionnairesanxietyburnoutdepressionmental healthpharmacists

Identifiers

PMID37947546
PMCPMC10648574
OpenAlexW4388009869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.